Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00666159 · ClinicalTrials.gov registry record · Phase 4

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

A Phase 4 study of Dermatitis, Atopic, sponsored by Astellas Pharma.

Completed
Registry status
Phase 4
Development phase
226
Enrollment target
12
Study locations

NCT00666159 is a Phase 4 study of Dermatitis, Atopic that has completed, run by Astellas Pharma. The registered enrollment target is 226 participants, below the 389-participant average among 29 other Dermatitis, Atopic trials with a reported enrollment target (42% lower). The trial reports 12 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00666159, a Phase 4 study of Dermatitis, Atopic, has completed, sponsored by Astellas Pharma.

COMPLETED
Registry status
Phase 4
Development phase
226 participants
Enrollment target
12
Study locations

Study Summary

Comparison of Protopic Ointment to Elidel Cream to assess the safety and efficacy in pediatric patients with Atopic Dermatitis

Conditions Studied

Dermatitis, Atopic

Interventions

  • DRUG tacrolimus ointment
  • DRUG pimecrolimus cream

Study Locations (12)

North Carolina

  • - Chapel Hill
  • - Wilmington
  • - Winston-Salem

Florida

  • - Miami
  • - Miami

Connecticut

  • - New Haven

Illinois

  • - Chicago

Massachusetts

  • - Boston

Michigan

  • - Clinton Township

Nebraska

  • - Omaha

Nevada

  • - Reno

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2002-12
Est. Completion 2003-05
Phase Phase 4

Sponsor

Astellas Pharma

165 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00666159

The ClinicalTrials.gov registry entry for NCT00666159 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 389-participant average among 29 other Dermatitis, Atopic trials with a reported enrollment target (42% lower). The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dermatitis, Atopic appearing as the primary indexed condition, and to 2 interventions - of which tacrolimus ointment is the first listed.

NCT00666159 reports 12 study locations spanning 9 distinct geographic areas - top geographies include North Carolina, Florida, Connecticut.

Frequently Asked Questions

What is clinical trial NCT00666159 about?

NCT00666159 is a clinical study titled "Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis". Comparison of Protopic Ointment to Elidel Cream to assess the safety and efficacy in pediatric patients with Atopic Dermatitis

What is the current status of trial NCT00666159?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 226 participants. The study started on 2002-12. Estimated completion is 2003-05.

What conditions does trial NCT00666159 study?

This clinical trial studies the following conditions: Dermatitis, Atopic.

What interventions are being tested in trial NCT00666159?

The interventions under investigation include: tacrolimus ointment (DRUG), pimecrolimus cream (DRUG).

Who is sponsoring clinical trial NCT00666159?

This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00666159 being conducted?

This trial has 12 study locations across Connecticut, Florida, Illinois, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dermatitis, Atopic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dermatitis, Atopic

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.